Prognostic significance of cyclooxygenase‐2 in cervical cancer: A meta‐analysis
Published data on the prognostic value of cyclooxygenase‐2 (COX‐2) overexpression in
cervical cancer are conflicting and heterogeneous. We performed a meta‐analysis to more …
cervical cancer are conflicting and heterogeneous. We performed a meta‐analysis to more …
Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
JH Hong, CS Tsai, CC Wang, CH Lai… - Chang Gung medical …, 2000 - europepmc.org
Background Adenocarcinomas/adenosquamous carcinomas (AC/ASC) are relatively
uncommon histological subtypes in cervical cancer. In this study, we retrospectively …
uncommon histological subtypes in cervical cancer. In this study, we retrospectively …
Postoperative chemoradiation therapy in high-risk cervical cancer: re-evaluating the findings of Gynecologic Oncology Group Study 109 in a large, population-based …
DM Trifiletti, S Swisher-McClure, TN Showalter… - International Journal of …, 2015 - Elsevier
Purpose To review the National Cancer Database (NCDB) to evaluate postoperative high-
risk cervical cancer patients for factors associated with a benefit from chemoradiation …
risk cervical cancer patients for factors associated with a benefit from chemoradiation …
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and …
G Ferrandina, M Distefano, D Smaniotto, A Morganti… - Gynecologic …, 2006 - Elsevier
OBJECTIVE.: The aim of this study was to investigate the role of anemia at presentation
(basal HB) and during treatment (nadir HB) as predictor of pathological response, as well as …
(basal HB) and during treatment (nadir HB) as predictor of pathological response, as well as …
[HTML][HTML] Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with …
R Kawaguchi, N Furukawa, H Kobayashi… - Journal of gynecologic …, 2013 - ncbi.nlm.nih.gov
Objective The aim of the present study was to assess prognostic factors for patients with
locally advanced cervical cancer treated with radiotherapy as the primary treatment and to …
locally advanced cervical cancer treated with radiotherapy as the primary treatment and to …
Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
Purpose: Chemoradiotherapy for locally advanced cervical cancer fails in over a third of
patients. Biomarkers with therapeutic implications are therefore needed. We investigated the …
patients. Biomarkers with therapeutic implications are therefore needed. We investigated the …
[HTML][HTML] Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer
VH De Almeida, AC de Melo, DD Meira… - Brazilian Journal of …, 2018 - SciELO Brasil
Cervical cancer is a public health problem and the molecular mechanisms underlying
radioresistance are still poorly understood. Here, we evaluated the modulation of key …
radioresistance are still poorly understood. Here, we evaluated the modulation of key …
Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis
AW Fyles, M Pintilie, P Kirkbride, W Levin… - Radiotherapy and …, 1995 - Elsevier
A retrospective analysis of 965 patients with invasive cervix cancer treated by radiation
therapy between 1976 and 1981 was performed in order to evaluate prognostic factors for …
therapy between 1976 and 1981 was performed in order to evaluate prognostic factors for …
[HTML][HTML] Survival of patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy according to histological subtype: a systematic …
G Yao, J Qiu, F Zhu, X Wang - Frontiers in Medicine, 2022 - frontiersin.org
Background Cervical cancer is a leading cause of morbidity and mortality for women
worldwide. Different histopathological cervical cancer subtypes (ie, adenocarcinoma …
worldwide. Different histopathological cervical cancer subtypes (ie, adenocarcinoma …
Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
L Rojas‐Puentes, AF Cardona, H Carranza… - Cancer …, 2016 - Wiley Online Library
We evaluated the association between epithelial–mesenchymal transition (EMT)‐derived
markers and expression of proteins associated with cell proliferation and tumor growth, as …
markers and expression of proteins associated with cell proliferation and tumor growth, as …